Navigation Links
Study explores the role of uncertainty in infectious disease modelling
Date:10/21/2013

Research by scientists at the University of Liverpool has found that greater consideration of the limitations and uncertainties present in every infectious disease model would improve its effectiveness/usefulness and value.

Infectious disease dynamical modelling plays a central role in planning for outbreaks of human and livestock diseases, in projecting how they might progress and guiding and informing policy responses.

Modelling is commissioned by governments or may be developed independently by researchers. It has been used to inform policy decisions for human and animal diseases such as SARS, H1N1 swine influenza, foot-and-mouth disease and is being used to inform action in the campaign to control bovine TB.

In a study published in PLOS One, researchers analysed scientific papers, interviews, policies, reports and outcomes of previous infectious diseases outbreaks in the UK to ascertain the role uncertainties played in previous models and how these were understood by both the designers of the model and the users of the model.

They found that many models used to respond to epidemics provided only cursory reference to the uncertainties of the information and data or the parameters used. Whilst the models were uncertain many still informed action.

Dr Rob Christley, from the University's Institute of Infection and Global Health, said: "It is accepted that models will never be able to predict 100% the size, shape or form of an outbreak and it is recognised that a level of uncertainty always exists in modelling. However, modellers often fear detailed discussion of this uncertainty will undermine the model in the eyes of policy makers.

"This study found that the uncertainties and limitations of a model are sometimes hidden and sometimes revealed, and that which occurs is context dependent.

"Whilst it isn't possible to calculate the level of uncertainty, a better understanding and communication of the model's limitations is needed and could lead to better policy."

A model is produced by individuals who have to decide what is important and need to bring together data and information which could include population data, age of population, proximity, type of disease. Uncertainty can occur at all stages of the process from weaknesses in the quality and type of data used, assumptions made about the infectious agent itself, and about the world in which the disease is circulating, all the way through to the technical aspects of the model.


'/>"/>

Contact: Sarah Stamper
sarah.stamper@liv.ac.uk
01-517-943-044
University of Liverpool
Source:Eurekalert

Related biology news :

1. Clean living is a luxury wild animals cant afford, study suggests
2. Study puts freshwater biodiversity on the map for planners and policymakers
3. What makes us left or right handed? New study rules out strong genetic factors
4. Study: Acidity can change cell membrane properties
5. Leading Pharma Company Selects Clinilabs to Conduct a Phase 1 Study of an Investigational Type 2 Diabetes Medication
6. $1.5 million NCI Grant to aid Huntsman Cancer Institute researcher study melanoma, sun damage link
7. Study finds steroids may persist longer in the environment than expected
8. New study offers hope for halting incurable citrus disease
9. Global study reveals new hotspots of fish biodiversity
10. Family Resiliency Center helps study how food-bank clients afford basic non-food items
11. New CU-Boulder-led study finds microbial clock may help determine time of death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... ... Supplyframe, the Industry Network for electronics hardware design and ... in Pasadena, Calif., the Design Lab’s mission is to bring together inventors and ... brought to market. , The Design Lab is Supplyframe’s physical representation of one ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... June 23, 2016 On Wednesday, June ... 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% ... at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the ... Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. ... BIND ). Learn more about these stocks by ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
Breaking Biology Technology: